Skip to content

Does the Volume of Medication Affect the Success of Labor Epidural Analgesia

Impact of Injected Volume on Programmed Intermittent Epidural Bolus Analgesia

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07684365
Acronym
EpiVol
Enrollment
70
Registered
2026-07-06
Start date
2026-08-15
Completion date
2027-12-31
Last updated
2026-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor Pain and to Reduce Pain

Keywords

epidural analgesia, Obstetric anesthesia, bupivacaine, fentanyl, programmed intermittent epidural bolus, labor pain

Brief summary

The purpose of this study is to evaluate whether changing the volume and concentration of a medication affects the quality of pain relief and the side effects associated with labor epidural analgesia.

Detailed description

This is a randomized, single blinded trial comparing epidural pain relief for labor when medications are delivered in one of two volumes/concentrations. Patients in each arm of the study will receive the same dose of medication, but one will be half as concentrated and twice the volume. The outcome will be the number of supplemental doses of medication that patients receive during labor via their patient-controlled analgesia button.

Interventions

DRUGadministration of bupivacaine 7.5 mg and fentanyl 24 mcg every 40 minutes

Dose of medication delivered using a programmed intermittent epidural bolus

Sponsors

Beth Israel Deaconess Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* 18 years of age or older * Gestational age of 36 weeks or greater * American Society of Anesthesiology physical status 2 * Induction of labor or early labor (cervical dilation \< 6cm) * Singleton gestation * Vertex presentation

Exclusion criteria

* Preeclampsia * Receiving magnesium sulfate * Having received narcotics within 4 hours * Multiple gestation * Major fetal anomalies or demise * Previous spine surgery * Known major spine pathology * Substance use disorder

Design outcomes

Primary

MeasureTime frameDescription
Patient controlled boluses receivedThe duration of labor until delivery of the neonateThe number of patient-controlled boluses received by the patient by pressing the patient-controlled analgesia (PCA) button for additional pain relief

Secondary

MeasureTime frameDescription
Patient controlled boluses requestsThe duration of labor until delivery of the neonateThe number of patient controlled boluses requested by pressing the PCA button for additional pain relief
Physician administered epidural bolusThe duration of labor until delivery of the neonateThe number of times that a physician supplies additional medication for the control of pain

Contacts

CONTACTElizabeth Amis
eamis@bidmc.harvard.edu(617) 667-1861
PRINCIPAL_INVESTIGATORPhilip Hess, MD

Beth Israel Deaconess Medical Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 7, 2026